Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - Euronext Paris - Matif - FR0013154002 - Common Stock - Currency: EUR

169.9  -0.1 (-0.06%)

Fundamental Rating

5

Taking everything into account, DIM scores 5 out of 10 in our fundamental rating. DIM was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of DIM get a neutral evaluation. Nothing too spectacular is happening here. DIM shows excellent growth, but is valued quite expensive already. With these ratings, DIM could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DIM was profitable.
In the past year DIM had a positive cash flow from operations.
In the past 5 years DIM has always been profitable.
Each year in the past 5 years DIM had a positive operating cash flow.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

DIM has a Return On Assets (2.46%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 5.14%, DIM is in line with its industry, outperforming 50.00% of the companies in the same industry.
DIM's Return On Invested Capital of 4.36% is on the low side compared to the rest of the industry. DIM is outperformed by 61.11% of its industry peers.
DIM had an Average Return On Invested Capital over the past 3 years of 10.41%. This is above the industry average of 6.95%.
The last Return On Invested Capital (4.36%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROIC 4.36%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of DIM (7.15%) is better than 61.11% of its industry peers.
DIM's Profit Margin has declined in the last couple of years.
The Operating Margin of DIM (14.05%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DIM has declined.
DIM's Gross Margin of 43.89% is fine compared to the rest of the industry. DIM outperforms 61.11% of its industry peers.
DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
DIM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DIM has been increased compared to 5 years ago.
DIM has a better debt/assets ratio than last year.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DIM has an Altman-Z score of 3.58. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.58, DIM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
DIM has a debt to FCF ratio of 5.03. This is a neutral value as DIM would need 5.03 years to pay back of all of its debts.
DIM's Debt to FCF ratio of 5.03 is in line compared to the rest of the industry. DIM outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.72 indicates that DIM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.72, DIM is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Altman-Z 3.58
ROIC/WACC0.56
WACC7.82%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that DIM should not have too much problems paying its short term obligations.
The Current ratio of DIM (1.85) is better than 61.11% of its industry peers.
A Quick Ratio of 1.14 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Quick ratio (1.14) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.14
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.91% over the past year.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 0.16% in the last year.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%

3.2 Future

DIM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.45% yearly.
Based on estimates for the next years, DIM will show a quite strong growth in Revenue. The Revenue will grow by 10.39% on average per year.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue Next Year9.39%
Revenue Next 2Y9.85%
Revenue Next 3Y10.49%
Revenue Next 5Y10.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

DIM is valuated quite expensively with a Price/Earnings ratio of 41.14.
83.33% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.03. DIM is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 30.82, DIM can be considered very expensive at the moment.
DIM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DIM is more expensive than 77.78% of the companies in the same industry.
DIM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 41.14
Fwd PE 30.82
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DIM is valued a bit more expensive than the industry average as 72.22% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DIM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.34
EV/EBITDA 26.38
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 24.81% in the coming years.
PEG (NY)1.72
PEG (5Y)9.81
EPS Next 2Y25.51%
EPS Next 3Y24.81%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.39%, DIM is not a good candidate for dividend investing.
DIM's Dividend Yield is slightly below the industry average, which is at 0.73.
Compared to an average S&P500 Dividend Yield of 2.40, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

32.84% of the earnings are spent on dividend by DIM. This is a low number and sustainable payout ratio.
The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (8/5/2025, 7:00:00 PM)

169.9

-0.1 (-0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-16 2025-10-16
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.54B
Analysts77.78
Price Target242.37 (42.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)-0.19%
PT rev (3m)-4.1%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)4.74%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)2.75%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 41.14
Fwd PE 30.82
P/S 5.79
P/FCF 28.34
P/OCF 18.8
P/B 4.16
P/tB N/A
EV/EBITDA 26.38
EPS(TTM)4.13
EY2.43%
EPS(NY)5.51
Fwd EY3.25%
FCF(TTM)6
FCFY3.53%
OCF(TTM)9.04
OCFY5.32%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)1.72
PEG (5Y)9.81
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROCE 5.47%
ROIC 4.36%
ROICexc 4.84%
ROICexgc 15.14%
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
FCFM 20.42%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Debt/EBITDA 4
Cap/Depr 95.85%
Cap/Sales 10.35%
Interest Coverage 2.25
Cash Conversion 123.84%
Profit Quality 285.66%
Current Ratio 1.85
Quick Ratio 1.14
Altman-Z 3.58
F-Score7
WACC7.82%
ROIC/WACC0.56
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.39%
Revenue Next 2Y9.85%
Revenue Next 3Y10.49%
Revenue Next 5Y10.39%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.34%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%